Zobrazeno 1 - 10
of 102
pro vyhledávání: '"M Carrillo Palau"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
P Sanz Segura, F Gomollón, S García García, M Vela, A Fernández-Clotet, R Muñoz, I García de la Filia, M García Prada, J A Ferrer Rosique, M J García, R de Francisco, L Arias, J Barrio, I Guerra, A Ponferrada Diaz, J P Gisbert, M Carrillo-Palau, X Calvet, L Márquez-Mosquera, B Gros, F Cañete, D Monfort, R E Madrigal, O Roncero, V Laredo, M Montoro, C Muñoz, B López-Cauce, R Lorente, A Fuentes, P Vega, D Martín, J Nerín de la Puerta, P Varela, D Casas-Deza, P Martínez, R Pajares, A J Lucendo, E Domènech, S García-López
Publikováno v:
Journal of Crohn's and Colitis. 17:i774-i775
Background Some patients with Inflammatory Bowel Disease (IBD) who are treated with anti-TNFα therapy develop a drug-induced psoriasis (IP) as an adverse event. There are some therapeutic approaches, being more frequent to change the biologic therap
Autor:
A Hernandez-Camba, J Rodriguez-Jimenez, M Carrillo Palau, L Ramos Lopez, L Perez-Mendez, E Martin-Nuñez, I Alonso, M Vela, N Hernandez Alverez Builla, L Arranz, A Hernandez, I Ferraz Amaro, J F Navarro-Gonzalez
Publikováno v:
Journal of Crohn's and Colitis. 17:i642-i643
Background Alpha klotho (α-Klotho) is an anti-aging protein recognized as a humoral factor with anti-oxidant and anti-inflammatory effects, showing a bidirectional relationship with inflammation, a main pathophysiologic factor in atherosclerosis. A
Autor:
M Calafat Sard, C Súria, F Mesonero, R de Francisco, C Yagüe Caballero, L de la Peña, A Hernández-Camba, A Marcè, B Gallego, N Martín-Vicente, M Rivero, M Iborra, I Guerra, M Carrillo-Palau, L Madero, B Burgueño, D Montfort, G Torres, M Teller, J Á Ferrer Rosique, P Vega Villaamil, C Roig, Á Ponferrada, E Betoré Glaría, Y Zabana, J P Gisbert, N Alcaide, B Camps, J Legido, M González Vivo, M M Bosca-Watts, I Pérez-Martínez, D Casas Deza, J Guardiola, L Arranz Hernández, M Navarro, F Gomollon, F Cañete, M Mañosa, E Domènech
Publikováno v:
Journal of Crohn's and Colitis. 17:i80-i81
Background The coexistence of immune-mediated diseases and non-pharmacological immunosuppression states are rare and might determine the natural history of the disease and therapeutic decisions of the physician. IBD guidelines recommend screening for
Autor:
A. Hernández-Camba, J. Rodríguez-Jiménez, M. Carrillo Palau, L. Ramos López, L. Pérez-Méndez, E. Martín-Núñez, I. Alonso, M. Vela, N. Hernández Alverez Builla, L. Arranz, A. Hernández, I. Ferraz Amaro, J.F. Navarro-González
Publikováno v:
Gastroenterología y Hepatología. 46:S110
Autor:
L Ramos Lopez, R Ramos-Díaz, I Alonso-Abreu, I Mourani-Padron, M Carrillo-Palau, M C Reygosa, S Medina-Chico, F Gutierrez-Nicolas, G J Nazco-Casariego, M Hernandez-Guerra
Publikováno v:
Journal of Crohn's and Colitis. 17:i644-i644
Background Therapeutic drug monitoring (TDM) is a valuable tool to optimize anti-TNF biologics in inflammatory bowel disease (IBD). However, for the non-anti-TNF agents (such as Ustekinumab-UST- an anti-IL12/23) TDM value and evidence in real-world I
Autor:
L Ramos Lopez, A Hernández, M Carrillo-Palau, A Hernández-Camba, I Alonso-Abreu, C Reygosa, M Vela, G E Rodríguez, Y González-Mendez, C Tardillo, L Arranz, F Benítez-Zafra, M Hernández-Guerra
Publikováno v:
Journal of Crohn's and Colitis. 16:i271-i272
Background During the COVID-19 pandemic, outpatient activity and the performance of complementary tests have been limited in order to optimize health care resources in patients with SARS-CoV2 infection according to the incidence of cases in each time
Autor:
L Ramos Lopez, M Carrillo-Palau, I Alonso-Abreu, C Reygosa, N Hernández-Buylla, C Amaral, A Hernández, F Benítez-Zafra, F Pérez-González, H Quintana-Díaz, M Hernández-Guerra
Publikováno v:
Journal of Crohn's and Colitis. 16:i592-i593
Background Vaccination against COVID19 prevents its severe forms and associated mortality and offers a promising action to control this pandemic. In Spain, by October 2021, 87.9% of the target population, including IBD patients had received the compl
Autor:
A Hernandez Camba, M Carrillo Palau, L Ramos, I Alonso, M Vela, A Hernández, L Arranz, N Hernández, M Hernández-Guerra, I Ferráz
Publikováno v:
Journal of Crohn's and Colitis. 16:i451-i452
Background Inflammatory bowel disease (IBD) has been associated with an abnormal lipid profile. Apolipoprotein C3 (ApoC3) is a key molecule of triglycerides metabolism that is known to be related to inflammation and cardiovascular (CV) disease. In th
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.